Investment
Features
FeesSafety
Academy
More
Pluang+

Trump warns South Korea to join $50B Alaska LNG project or face higher costs, amid investment deal confusion.

Market News
04 Oct 2026
CNBC
View Source
Neutral
Trump warns South Korea to join $50B Alaska LNG project or face higher costs, amid investment deal confusion.

U.S. President Donald Trump warned South Korea to sign on soon to the $50 billion Alaska LNG project or face higher charges, possibly tariffs, though he did not specify details. South Korea is still evaluating the project based on commercial viability and legal procedures, and has not finalized participation. Trump also announced an additional $8.4 billion oil recovery project, which South Korean officials say was not part of any agreement and are seeking clarification on. This highlights ongoing discrepancies between Washington and Seoul over energy and infrastructure investments.

The Alaska LNG project and related U.S.-South Korea energy talks provide context for this market snapshot. For readers following Energy-sector US stocks on Pluang, as of Oct 05, 2026 08:02 WIB, 30 of 38 stocks rose while 8 fell. Notable movers include PBR at USD 22.76 with a 9.06% increase, MPC at USD 422.31 up 6.80%, and OXY at USD 58.10 rising 5.03%. Typical hold times range from 26 to 91 days among these stocks.

More News

Zcash hires lobbyist to influence US crypto policies, boosting Bitcoin price outlook for 2026

Zcash hires lobbyist to influence US crypto policies, boosting Bitcoin price outlook for 2026

Zcash has registered a lobbyist in Washington, DC, aiming to influence US cryptocurrency policies, including tax rules and market structure. This move is part of Zcash's effort to promote privacy-focused crypto regulations. Market watchers see this a...

Market News
Bullish
4 hours ago
CSL inks $1.6B deal to develop rare kidney and liver disease drug lixudebart

CSL inks $1.6B deal to develop rare kidney and liver disease drug lixudebart

CSL Limited has signed an exclusive licensing deal with Swiss biotech Alentis Therapeutics to develop and commercialize lixudebart, a drug in Phase 2 trials for rare autoimmune kidney disease ANCA-associated vasculitis. The drug targets inflammation ...

Company Fundamentals
Bullish
4 hours ago
GraniteShares 2x Long MU ETF rated Hold amid near-term volatility despite Micron's strong long-term outlook

GraniteShares 2x Long MU ETF rated Hold amid near-term volatility despite Micron's strong long-term outlook

GraniteShares 2x Long MU Daily ETF (MULL), which offers double the daily performance of Micron stock, is rated Hold due to expected short-term volatility. Micron's growth prospects remain strong, supported by expanding production capacity, high deman...

Market News
Neutral
4 hours ago
Ether short position on Hyperliquid shows $30M unrealized loss amid market moves

Ether short position on Hyperliquid shows $30M unrealized loss amid market moves

A wallet holding a large short position of about 78,000 Ether (ETH) on Hyperliquid experienced an unrealized loss of approximately $30.29 million as of October 5. The position was valued at around $213 million with an average opening price of $2,340 ...

Market News
Bearish
4 hours ago
Bitcoin nears $87K as October gains build, eyeing $94K with strong seasonal and institutional support.

Bitcoin nears $87K as October gains build, eyeing $94K with strong seasonal and institutional support.

Bitcoin's price climbed to $86,771 on October 4, closing in on the recent high of $87,177 from the previous Friday. Historically, October has been a strong month for Bitcoin, with gains in 10 of the last 13 years and a median increase of 12.7%, sugge...

Market News
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App